Curcumin per Memory Loss
C Evidenze Evidenza limitata da studi di piccole dimensioni, ma esistono alcuni segnali positivi.Preclinical studies show memory enhancement with curcumin in Alzheimer's models. Human studies show limited but positive trends in working memory, primarily with enhanced bioavailability formulations.
<\/script>\n`;
},
get iframeSnippet() {
const domain = 'braincited.com';
const params = 'ingredient\u003Dcurcumin\u0026condition\u003Dmemory\u002Dloss';
return ``;
},
get activeSnippet() {
return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet;
},
copySnippet() {
navigator.clipboard.writeText(this.activeSnippet).then(() => {
this.copied = true;
setTimeout(() => { this.copied = false; }, 2000);
});
}
}"
@keydown.escape.window="open = false"
@click.outside="open = false">
C
In sintesi
Preclinical studies show memory enhancement with curcumin in Alzheimer's models. Human studies show limited but positive trends in working memory, primarily with enhanced bioavailability formulations.
Key Study Findings
In Vitro
Curcumin Improves Hippocampal Cell Bioenergetics, Redox and Inflammatory Markers, and Synaptic Proteins, Regulating Mitochondrial Calcium …
Dose: None
vs: MitoQ (mitochondrial antioxidant)
Outcome: Hippocampal bioenergetics and calcium homeostasis
Effetto: None
None
Popolazione: C57BL6 mice hippocampal slices (4-6 months old)
Review
Targeting Liquid-Liquid Phase Separation and Autophagy in Alzheimer's Disease: Insights into Molecular Mechanisms and Therapeutic …
Dose: None
vs: None
Outcome: AD pathology modulation via LLPS and autophagy
Effetto: None
None
Popolazione: Alzheimer's disease (review of mechanisms)
In Vitro
4 weeks
Curcumin-enhanced stem cell exosomes: A novel approach to modulating neuroinflammation and improving cognitive function in …
Dose: 30 ug/body, 4 injections over 30 days
vs: MSC-EXO alone; AD (STZ) rat model
Outcome: Memory and neuroinflammation in AD rats
Effetto: None
None
Popolazione: STZ-induced AD male Wistar rats (250+/-50g)
In Vitro
4 weeks
Co-administration of coenzyme Q10 and curcumin mitigates cognitive deficits and exerts neuroprotective effects in aluminum …
Dose: 100 mg/kg each
vs: AlCl3-induced AD aged mice; individual high-dose
Outcome: Cognitive deficits and neuroprotection
Effetto: None
None
Popolazione: 18-month old male Balb/c mice with AlCl3-induced AD
Review
Mechanisms Linking Obesity, Insulin Resistance, and Alzheimer's Disease: Effects of Polyphenols and Omega-3 Polyunsaturated Fatty …
Dose: None
vs: None
Outcome: None
Effetto: None
None
Popolazione: None
Other
8 weeks
Increases in brain catecholamine levels counteract memory deficits and reduces Aβ deposition in 5XFAD male …
Dose: None
vs: Vehicle-treated 5XFAD mice
Outcome: Memory improvement and Aβ deposition in 5XFAD mice
Effetto: None
None
Popolazione: 5XFAD male Alzheimer's disease model mice
Key Statistics
8
Studi
600
Partecipanti
↔
Mixed
C
Grado
Referenced Papers
European journal of …
2025
10 citazioni
Nutrients
2025
10 citazioni
Experimental gerontology
2025
7 citazioni
Neurotoxicity research
2025
7 citazioni
Food science & …
2025
4 citazioni
Biomedicine & pharmacotherapy …
2025
1 citazioni
Neurochemical research
2025
Degenerative neurological and …
2024
66 citazioni
Scientific reports
2024
42 citazioni
Ageing research reviews
2024
41 citazioni
Chinese medicine
2024
29 citazioni
Ageing research reviews
2024
24 citazioni
Nanoencapsulated Curcumin: Enhanced Efficacy in Reversing Memory Loss in An Alzheimer Disease Model.
Other
Brain sciences
2024
14 citazioni
Molecules (Basel, Switzerland)
2024
13 citazioni
Research Mechanism and Progress of the Natural Compound Curcumin in Treating Alzheimer´s Disease.
Review
Mini reviews in …
2024
9 citazioni
Pharmaceutical nanotechnology
2024
2 citazioni
Phytomedicine : international …
2023
15 citazioni
Molecules (Basel, Switzerland)
2022
30 citazioni
Medicine
2022
25 citazioni
Biomedicines
2022
17 citazioni
International journal of …
2022
16 citazioni
Foods (Basel, Switzerland)
2022
14 citazioni
Biomedical reports
2022
12 citazioni
Iranian journal of …
2022
5 citazioni
Cells
2021
24 citazioni
Research in veterinary …
2021
14 citazioni
Redox biology
2020
100 citazioni
Brain and behavior
2020
45 citazioni
Potential therapeutic effect of curcumin, a natural mTOR inhibitor, in tuberous sclerosis complex.
Other
Phytomedicine : international …
2019
14 citazioni
Environmental toxicology
2017
36 citazioni
Medical science monitor …
2017
7 citazioni
Nutrients
2015
191 citazioni
BioMed research international
2014
108 citazioni
Current pharmaceutical biotechnology
2014
67 citazioni
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
Dosaggi di uso comune
- general:
- 500-2,000 mg/day of enhanced bioavailability form
- cognitivesupport:
- 90-180 mg/day Theracurmin or equivalent
Limite massimo: Well-tolerated up to 8,000 mg/day; 12,000 mg/day short-term
Dosaggi studiati nella ricerca
| Dosaggio | Durata | Effetto | N |
|---|---|---|---|
| None | -- | Positive | -- |
| None | -- | Positive | -- |
| 30 ug/body, 4 injections over 30 days | 4 weeks | Positive | -- |
| 100 mg/kg each | 4 weeks | Positive | -- |
| None | -- | Mixed | -- |
| None | 8 weeks | Positive | -- |
| None | -- | Positive | -- |
| None | -- | Positive | -- |
Momento migliore per l'assunzione: With meals containing fat and black pepper (piperine) for absorption
Safety & Side Effects
Effetti collaterali segnalati
- ⚠ Gastrointestinal discomfort (nausea, diarrhea)
- ⚠ Headache
- ⚠ Skin rash (rare)
- ⚠ Yellow staining of teeth with powder forms
Interazioni note
- ● Anticoagulants (may increase bleeding risk)
- ● Antidiabetic drugs (may enhance blood sugar lowering)
- ● CYP450 substrates (may affect drug metabolism)
- ● Iron supplements (curcumin may chelate iron)
Livello di assunzione massimo tollerabile: Well-tolerated up to 8,000 mg/day; 12,000 mg/day short-term
Consultare sempre il proprio medico prima di iniziare qualsiasi integratore.Consultate sempre il vostro medico prima di iniziare qualsiasi integratore.
Frequently Asked Questions
Does Curcumin help with Memory Loss?
Based on 8 studies with 600 participants, there is limited but promising evidence that Curcumin may support Memory Loss management. Our evidence grade is C (Some Evidence).
How much Curcumin should I take for Memory Loss?
Studies have used various dosages. A commonly studied range is 500-2,000 mg/day of enhanced bioavailability form. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Curcumin?
Reported side effects may include Gastrointestinal discomfort (nausea, diarrhea), Headache, Skin rash (rare), Yellow staining of teeth with powder forms. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Curcumin and Memory Loss?
We rate the evidence as Grade C (Some Evidence). This rating is based on 8 peer-reviewed studies with 600 total participants. The overall direction of effect is mixed.
Related Evidence
Altri ingredienti per Memory Loss
Curcumin per altre condizioni
References
- [1] Mohammad-Ali Bashirrohelleh et al.. Eur J Pharmacol. 2025. Curcumin-enhanced stem cell exosomes: A novel approach to modulating neuroinflammation and improving cognitive function in a rat model of Alzheimer's … doi:10.1016/j.ejphar.2025.177695 PubMed
- [2] Mahsa Yavari et al.. Nutrients. 2025. Mechanisms Linking Obesity, Insulin Resistance, and Alzheimer's Disease: Effects of Polyphenols and Omega-3 Polyunsaturated Fatty Acids. doi:10.3390/nu17071203 PubMed
- [3] Nida Rasheed et al.. Exp Gerontol. 2025. Co-administration of coenzyme Q10 and curcumin mitigates cognitive deficits and exerts neuroprotective effects in aluminum chloride-induced Alzheimer's disease in aged … doi:10.1016/j.exger.2024.112659 PubMed
- [4] Claudia Jara et al.. Neurotox Res. 2025. Curcumin Improves Hippocampal Cell Bioenergetics, Redox and Inflammatory Markers, and Synaptic Proteins, Regulating Mitochondrial Calcium Homeostasis. doi:10.1007/s12640-024-00726-y PubMed
- [5] Guifei Chen et al.. Food Sci Nutr. 2025. Polyphenols and Alzheimer's Disease: A Review on Molecular and Therapeutic Insights With In Silico Support. doi:10.1002/fsn3.70496 PubMed
- [6] Eunbi Cho et al.. Biomed Pharmacother. 2025. Increases in brain catecholamine levels counteract memory deficits and reduces Aβ deposition in 5XFAD male mice. doi:10.1016/j.biopha.2025.118764 PubMed
- [7] Xiaopeng Li et al.. Neurochem Res. 2025. Targeting Liquid-Liquid Phase Separation and Autophagy in Alzheimer's Disease: Insights into Molecular Mechanisms and Therapeutic Potential. doi:10.1007/s11064-025-04623-4 PubMed
- [8] Prabhash Nath Tripathi et al.. Degener Neurol Neuromuscul Dis. 2024. Review of Pharmacotherapeutic Targets in Alzheimer's Disease and Its Management Using Traditional Medicinal Plants. doi:10.2147/DNND.S452009 PubMed
- [9] Tiago Nicoliche et al.. Sci Rep. 2024. Antiviral, anti-inflammatory and antioxidant effects of curcumin and curcuminoids in SH-SY5Y cells infected by SARS-CoV-2. doi:10.1038/s41598-024-61662-7 PubMed
- [10] JinJin Pei et al.. Ageing Res Rev. 2024. Curcumin-loaded polymeric nanomaterials as a novel therapeutic strategy for Alzheimer's disease: A comprehensive review. doi:10.1016/j.arr.2024.102393 PubMed
- [11] Zhihan Chen et al.. Chin Med. 2024. A review on traditional Chinese medicine natural products and acupuncture intervention for Alzheimer's disease based on the neuroinflammatory. doi:10.1186/s13020-024-00900-6 PubMed
- [12] Faizan Ahmad et al.. Ageing Res Rev. 2024. Evolving therapeutic interventions for the management and treatment of Alzheimer's disease. doi:10.1016/j.arr.2024.102229 PubMed
- [13] Anne Suély Pinto Savall et al.. Brain Sci. 2024. Nanoencapsulated Curcumin: Enhanced Efficacy in Reversing Memory Loss in An Alzheimer Disease Model. doi:10.3390/brainsci14020130 PubMed
- [14] Bianca Sânziana Daraban et al.. Molecules. 2024. Latest Perspectives on Alzheimer's Disease Treatment: The Role of Blood-Brain Barrier and Antioxidant-Based Drug Delivery Systems. doi:10.3390/molecules29174056 PubMed
- [15] Li Li et al.. Mini Rev Med Chem. 2024. Research Mechanism and Progress of the Natural Compound Curcumin in Treating Alzheimer´s Disease. doi:10.2174/0113895575263783231009051957 PubMed
- [16] Shakeel Ahmed Ansari et al.. Pharm Nanotechnol. 2024. Current Updates on Nanotechnology-based Drug Delivery Platforms for Treating Alzheimer's with Herbal Drugs. doi:10.2174/0122117385335626241204165702 PubMed
- [17] Yuan Chen et al.. Phytomedicine. 2023. Fucoxanthin, a marine derived carotenoid, attenuates surgery-induced cognitive impairments via activating Akt and ERK pathways in aged mice. doi:10.1016/j.phymed.2023.155043 PubMed
- [18] Haya Hussain et al.. Molecules. 2022. Attenuation of Scopolamine-Induced Amnesia via Cholinergic Modulation in Mice by Synthetic Curcumin Analogs. doi:10.3390/molecules27082468 PubMed
- [19] Xinyan Wu et al.. Medicine (Baltimore). 2022. A network pharmacology approach to identify the mechanisms and molecular targets of curcumin against Alzheimer disease. doi:10.1097/MD.0000000000030194 PubMed
- [20] Haya Hussain et al.. Biomedicines. 2022. Synthetic Mono-Carbonyl Curcumin Analogues Attenuate Oxidative Stress in Mouse Models. doi:10.3390/biomedicines10102597 PubMed
- [21] Massimiliano Cuccioloni et al.. Int J Mol Sci. 2022. Enhancing the Amyloid-β Anti-Aggregation Properties of Curcumin via Arene-Ruthenium(II) Derivatization. doi:10.3390/ijms23158710 PubMed
- [22] Suksan Changlek et al.. Foods. 2022. Curcumin Suppresses Lead-Induced Inflammation and Memory Loss in Mouse Model and In Silico Molecular Docking. doi:10.3390/foods11060856 PubMed
- [23] Thanyaphon Phothi et al.. Biomed Rep. 2022. Effects of curcumin and γ-oryzanol solid dispersion on the brain of middle-aged rats. doi:10.3892/br.2022.1542 PubMed
- [24] Khatereh Kharazmi et al.. Iran J Med Sci. 2022. Protection against Morphine-Induced Inhibitory Avoidance Memory Impairment in Rat by Curcumin: Possible Role of Nitric Oxide/ cAMP-Response Element Binding Protein … doi:10.30476/IJMS.2022.92131.2339 PubMed
- [25] Oana M Dumitrascu et al.. Cells. 2021. Retinal Venular Tortuosity Jointly with Retinal Amyloid Burden Correlates with Verbal Memory Loss: A Pilot Study. doi:10.3390/cells10112926 PubMed
- [26] R L Moretti et al.. Res Vet Sci. 2021. Behavioral and morphological effects of resveratrol and curcumin in rats submitted to doxorubicin-induced cognitive impairment. doi:10.1016/j.rvsc.2021.09.009 PubMed
- [27] Margrethe A Olesen et al.. Redox Biol. 2020. Premature synaptic mitochondrial dysfunction in the hippocampus during aging contributes to memory loss. doi:10.1016/j.redox.2020.101558 PubMed
- [28] Yan Xu et al.. Brain Behav. 2020. Bisdemethoxycurcumin inhibits oxidative stress and antagonizes Alzheimer's disease by up-regulating SIRT1. doi:10.1002/brb3.1655 PubMed
- [29] Chu-Jen Kuo et al.. Phytomedicine. 2019. Potential therapeutic effect of curcumin, a natural mTOR inhibitor, in tuberous sclerosis complex. doi:10.1016/j.phymed.2018.09.203 PubMed
- [30] Pauline da Costa et al.. Environ Toxicol. 2017. Curcumin attenuates memory deficits and the impairment of cholinergic and purinergic signaling in rats chronically exposed to cadmium. doi:10.1002/tox.22213 PubMed
- [31] Fu-Chun Zhao et al.. Med Sci Monit. 2017. Design and Development of a Novel Chalcone Derivative as an Anticholinesterase Inhibitor for Possible Treatment of Dementia. doi:10.12659/msm.901842 PubMed
- [32] Jessica E Beilharz et al.. Nutrients. 2015. Diet-Induced Cognitive Deficits: The Role of Fat and Sugar, Potential Mechanisms and Nutritional Interventions. doi:10.3390/nu7085307 PubMed
- [33] Christopher Millington et al.. Biomed Res Int. 2014. Chronic neuroinflammation in Alzheimer's disease: new perspectives on animal models and promising candidate drugs. doi:10.1155/2014/309129 PubMed
- [34] D Sheeja Malar et al.. Curr Pharm Biotechnol. 2014. Dietary polyphenols for treatment of Alzheimer's disease--future research and development. doi:10.2174/1389201015666140813122703 PubMed
Avvertenza FDA: Queste affermazioni non sono state valutate dalla Food and Drug Administration. I prodotti e le informazioni presenti su questo sito web non sono destinati a diagnosticare, trattare, curare o prevenire alcuna malattia. I gradi di evidenza presentati si basano sulla nostra analisi della ricerca pubblicata e sottoposta a revisione paritaria e non costituiscono consulenza medica. Consultate sempre il vostro medico prima di iniziare qualsiasi regime di integrazione.